FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)

View source ↗

Summary

FDA approves a supplemental application for ondansetron from AvPAK under an ANDA. This action updates the labeling/approval status of this generic antiemetic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)